U-Blot® Research Grade AltumomabCat. No. WA1060Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade AltumomabCat. No. WA1060
U-Blot® Research Grade AltrakinceptCat. No. WA1059
U-Blot® Research Grade AlteplaseCat. No. WA1058
U-Blot® Research Grade AlsevalimabCat. No. WA1057
U-Blot® Research Grade alpitatugCat. No. WA1056
U-Blot® Research Grade AlomfilimabCat. No. WA1055
U-Blot® Research Grade AlnuctamabCat. No. WA1054
U-Blot® Research Grade AlirocumabCat. No. WA1053
U-Blot® Research Grade AlextatugCat. No. WA1052
U-Blot® Research Grade aletekitugCat. No. WA1051
U-Blot® Research Grade AlemtuzumabCat. No. WA1050
U-Blot® Research Grade AlefaceptCat. No. WA1049